Allergan CEO defends Botox from new challenger - Forbes

Read More

Allergan CEO defends Botox from new challenger Forbes, NY Barely a week after the Food and Drug Administration cleared way for a second anti-wrinkle drug, Botox maker Allergan ( AGN - news - people ) is defending its top product as it also fights against an economic downturn that has consumers cutting back on ...